Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

Similar documents
The uneven playing field: Inequi3es in cancer care and outcomes in New Zealand

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of

Cancer, Care and Comorbidity. Associate Professor Diana Sarfati

Trends and disparities in cancer in Aotearoa/ NZ

C3: Cancer, Care and Comorbidity

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

Implementing of Population-based FOBT Screening

The health economic landscape of cancer in Europe

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Caring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3

Table 6.1 Summary information for colorectal cancer in Ireland,

The cancer burden in the European Union and the European Region: the current situation and a way forward

LEBANON. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

GERMANY. WCPT COUNTRY PROFILE December 2018

Ethnic inequalities in mortality: Trends and explanations,

UK bowel cancer care outcomes: A comparison with Europe

Smokefree Policies in Europe: Are we there yet?

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

THE NEW ZEALAND MEDICAL JOURNAL

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

Numbers and Narratives

Allied Health: Sustainable Integrated Health Care for all Australians

Overview of drug-induced deaths in Europe - What does the data tell us?

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

European Partnership for Screening

Cross Border Genetic Testing for Rare Diseases

CARDIOVASCULAR DISEASE AND DIABETES:

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Differences make a Difference

What were the key findings from the routinely-collected data?

Bowel Cancer Quality Improvement Report

Screening for Cervical Cancer in Europe

Table 7.1 Summary information for lung cancer in Ireland,

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

The OECD Health Care Quality Indicators Project

THE NEW ZEALAND MEDICAL JOURNAL

Hazardous drinking in 2011/12: Findings from the New Zealand Health Survey

Best practices in collecting and processing data in CRC screening and after it

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Engagement in language assessment / Regions of Europe

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Where we stand in EFORT

Indicators of suicide among people with serious mental illness

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Main developments in past 24 hours

Overall survival: 1 st line therapy

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Table 9.1 Summary information for stomach cancer in Ireland,

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Alcohol Prevention Day

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

European Collaboration on Dementia. Luxembourg, 13 December 2006

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Prevention of Oral Cancer Special Interest Working Group

The Urgency of the Situation: The Cost of Childhood Obesity for Society

Monthly measles and rubella monitoring report

THE NEW ZEALAND MEDICAL JOURNAL

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

HPV, Cancer and the Vaccination Programme

Louisville '19 Attachment #69

Q1 What age are you?

The Risk of Alcohol in Europe. Bridging the Gap June 2004

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

EHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction?

World Connections Committee (WCC) Report

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

EuropaColon Uniting citizens in the fight against colorectal cancer. Zorana Maravic Director of Group Development May, 2013

Where do EU Contries set the limit for low risk drinking.

Correction to: The education gradient in cancer screening participation: a consistent phenomenon across Europe?

Underage drinking in Europe

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Dr Chris Jackson. Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago

Chapter 6: Combined Cardiovascular Risk Factors

European Association of Dental Public Health Prevention of Oral Cancer

DECLARATION OF CONFLICT OF INTEREST. None

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Rheumatoid Arthritis Disease Burden and Access to Treatment

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York

Transcription:

Colorectal cancer New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

4.8 5.5 11.0 11.1 11.6 11.9 Source: OECD Health Data 2011. 14.3 12.6 17.1 14.0 21.3 14.3 16.5 14.5 12.7 14.8 21.6 15.6 18.2 16.2 18.3 16.3 18.5 16.3 17.6 16.6 18.0 16.8 21.5 17.0 17.2 17.0 20.2 17.8 18.3 20.4 18.5 19.5 18.9 22.8 19.2 23.1 19.5 19.9 20.2 21.0 20.6 19.8 20.9 24.3 21.2 20.7 21.4 27.0 24.8 27.0 25.3 24.5 25.5 34.3 26.0 31.0 27.7 37.6 33.1 NZ has high death rates from colorectal cancer Age-standardised rates per 100 000 population 2000 2009 40 35 30 25 20 15 10 5 0

4.8 5.5 11.0 11.1 11.6 11.9 Source: OECD Health Data 2011. 14.3 12.6 17.1 14.0 21.3 14.3 16.5 14.5 12.7 14.8 21.6 15.6 18.2 16.2 18.3 16.3 18.5 16.3 17.6 16.6 18.0 16.8 21.5 17.0 17.2 17.0 20.2 17.8 18.3 20.4 18.5 19.5 18.9 22.8 19.2 23.1 19.5 19.9 20.2 21.0 20.6 19.8 20.9 24.3 21.2 20.7 21.4 27.0 24.8 27.0 25.3 24.5 25.5 34.3 26.0 31.0 27.7 37.6 33.1 NZ has high death rates from colorectal cancer Age-standardised rates per 100 000 population 2000 2009 40 35 30 25 20 15 10 5 0

In New Zealand Around 3000 CRC every year of which about a third are rectal cancers in New Zealand Colorectal cancer is the second highest cause of cancer death in New Zealand

Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

Incidence rates of CRC are coming down Males Females Ministry of Health. 2010. Cancer Projections: Incidence 2004 08 to 2014 18. Wellington: Ministry of Health.

Number of cases of CRC are going up Ministry of Health. 2012. Cancer: New registrations and deaths 2009. Wellington: Ministry of Health.ealth.

Colorectal cancer: incidence is lower for Maori... But increasing Point number hdgdhu skjojsd asdsd Sdfsd sdfsds lkl; Sdasd gh fgdfg dfg d dfgg Maori Pacific European/ Other Asian Blakely et al. CancerTrends: Trends in Incidence by Ethnic and Socioeconomic Group, New Zealand 1981-2004.

Primary prevention of CRC Strong cohort effects Early life exposures? Dietary factors Physical inactivity Overweight/ obesity Smoking Alcohol Daily aspirin

Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

International comparison: Five-year relative survival in OECD countries 2004-2009 1997-2002 Japan Iceland Belgium United States Korea Canada Norway Austria New Zealand Finland Netherlands Malta Sweden Germany OECD (16) Singapore Portugal France Slovenia Denmark United Kingdom Ireland Czech Republic Latvia 68.0 67.3 66.1 64.7 64.5 62.5 63.7 52.6 63.4 59.1 63.1 57.0 63.1 57.1 62.1 57.0 61.8 58.9 61.0 57.9 60.8 60.7 57.3 60.4 53.3 59.9 54.6 57.8 57.5 57.4 57.0 55.8 45.5 55.5 50.1 53.3 48.1 52.9 49.0 49.6 41.1 38.6 0 25 50 75 100

Survival rates are improving over time Excess mortality rate has been reducing by 27% each 10 years since early 1990 s for those diagnosed with colorectal cancer Soeberg M, Blakely T, Sarfati D et al (2012). Cancer Trends: Trends in Survival by Ethnic and Socioeconomic Group, New Zealand 1991 2004. Wellington: University of Otago and Ministry of Health.

Not all good news (inequities)

Why ethnic inequities in cancer survival? More aggressive/ advanced tumours? Patient comorbidity? Health care quality and/or access?

Ethnic inequities in colon cancer survival 40% Excess mortality risk (Maori/non-Maori) 30% 20% 10% Comorbidity and treatment/health service factors each accounted for a third of the survival difference. 0% Unadjusted Demographics + Disease factors + Patient factors Risk adjustments + Treatment + Health service access Hill S, Sarfati D et al. Cancer. 2010: 116; 3205-14.

Ethnic inequities in colon cancer survival Percentage of cohort (stage III) 100 90 80 70 60 50 40 30 20 Referred to oncologist Reviewed by oncologist Offered adjuvant chemo Received adjuvant chemo Started within 8 weeks 10 0 Māori non-māori Hill S, Sarfati D, et al J Epidemiol Comm Health 2010: 64; 117-23

Not just colon cancer Māori were four times less likely to receive curative rather than palliative anticancer treatment for nonmetastatic disease compared with Europeans even after adjusting for age, gender, NZDep, CCI [comorbidity], tumor type, stage and patient declining management. Stevens W, Stevens G et al. Ethnic differences in the management of lung cancer in NZ. J Thoracic Oncol 2008.

Bowel cancer mortality: What s happening over time? Shaw C, Blakely T, Sarfati D, et al. Trends in colorectal cancer mortality by ethnicity and socioeconomic position in New Zealand 1981-1999: One country, many stories. Aust NZ J Public Health. 2006; 30 (1): 64-70. Point number hdgdhu skjojsd asdsd Sdfsd sdfsds lkl; Sdasd gh fgdfg dfg d dfgg

Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

Screening Waitemata DHB 2 yearly ifobt for those aged 50-74 years.

How is the pilot programme going? Participation: Participation rate 70% 60% 50% 40% 30% 20% 10% Desirable rate 0% Maori Pacific Asian Other Ministry of Health 2013

How is the pilot programme going? Around 130 cancers detected to Sept last year High detection of advanced adenomas Very high acceptance of colonoscopy

How is the pilot programme going? 50 45 40 35 30 25 20 15 Screened diagnoses Colon Cancer study 10 5 0 1 2 3 4 TNM Stage at diagnosis

Where to from here for bowel cancer? Primary prevention Screening programme Minimum treatment standards Data availability